Showing results (31-40 of 188) with videos related to
Sort By:
Pageof 19
Journal of Neuro-Oncology|October 26, 1999
Combined treatment modality for anaplastic oligodendroglioma: a phase II studyB Jeremic, Y Shibamoto, D Gruijicic, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 18, 2013
Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiencyD Miljic, P Miljic, M Doknic, et al.Journal of Endocrinological Investigation|May 19, 2010
Psychiatric and neuropsychological changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapyN P Maric, M Doknic, D Pavlovic, et al.Medicina (Kaunas, Lithuania)|July 2, 2021
Trends of Stomach Cancer in Central SerbiaMiodrag M Stojanovic, Natasa K Rancic, Marija R Andjelkovic Apostolovic, et al.Journal of Neuro-Oncology|December 3, 1999
Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II studyB Jeremic, Y Shibamoto, D Grujicic, et al.Rheumatology International|September 9, 2011
Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenonSlavica Pavlov-Dolijanovic, Nemanja S Damjanov, Roksanda M Stojanovic, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1999
Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II studyB Jeremic, Y Shibamoto, D Grujicic, et al.Journal of Neuro-Oncology|June 2, 2001
Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II studyB Jeremic, Y Shibamoto, D Grujicic, et al.Chemical Communications (Cambridge, England)|March 17, 2023
Paper card-like electrochemical platform as a smart point-of-care device for reagent-free glucose measurement in tearsLuca Fiore, Ankita Sinha, Narjiss Seddaoui, et al.Frontiers in Neurology|January 26, 2023
Metabolomics as a potential tool for monitoring patients with aneurysmal subarachnoid hemorrhageNebojsa Lasica, Vidak Raicevic, Nikola M Stojanovic, et al.Pageof 19